Arcellx (ACLX) Depreciation & Amortization (CF) (2021 - 2025)

Arcellx's quarterly Depreciation & Amortization (CF) came in at $1.6 million in Q4 2025, down 8.27% year-on-year from $1.8 million in Q4 2024, and down 10.96% quarter-over-quarter from $1.8 million in Q3 2025.

Arcellx has reported Depreciation & Amortization (CF) for 5 years, with the latest figure at $1.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) fell 8.27% year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2025 stood at $6.7 million (up 28.72% YoY), and the FY2025 full-year result was $6.7 million, up 28.72% from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 stood at $1.6 million, down from $1.8 million in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $1.8 million in Q3 2025, with the low at $207000.0 in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $813400.0, with a median of $443000.0 recorded in 2023.
  • Year-over-year, Depreciation & Amortization (CF) soared 198.43% in 2024 and slipped 8.27% in 2025.
  • Tracing ACLX's Depreciation & Amortization (CF) over 5 years: stood at $331000.0 in 2021, then advanced by 25.68% to $416000.0 in 2022, then jumped by 73.56% to $722000.0 in 2023, then soared by 147.78% to $1.8 million in 2024, then dropped by 8.27% to $1.6 million in 2025.
  • The last three Depreciation & Amortization (CF) figures came in at $1.6 million (Q4 2025), $1.8 million (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1,395.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 55.90 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 123.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 13.55 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 1.64 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.64 Mn
Dec 31, 2025 1.64 Mn
Sep 30, 2025 1.84 Mn
Sep 30, 2025 1.84 Mn
Jun 30, 2025 1.62 Mn
Jun 30, 2025 1.62 Mn
Mar 31, 2025 1.58 Mn
Mar 31, 2025 1.58 Mn
Dec 31, 2024 1.79 Mn
Dec 31, 2024 1.79 Mn
Sep 30, 2024 1.33 Mn
Sep 30, 2024 1.33 Mn
Jun 30, 2024 1.24 Mn
Jun 30, 2024 1.24 Mn
Mar 31, 2024 826,000.00
Mar 31, 2024 826,000.00
Dec 31, 2023 722,000.00
Dec 31, 2023 722,000.00
Sep 30, 2023 447,000.00
Sep 30, 2023 447,000.00
Jun 30, 2023 439,000.00
Jun 30, 2023 439,000.00
Mar 31, 2023 432,000.00
Mar 31, 2023 432,000.00
Dec 31, 2022 416,000.00
Dec 31, 2022 416,000.00
Sep 30, 2022 340,000.00
Sep 30, 2022 340,000.00
Jun 30, 2022 302,000.00
Jun 30, 2022 302,000.00
Mar 31, 2022 263,000.00
Mar 31, 2022 263,000.00
Dec 31, 2021 331,000.00
Dec 31, 2021 331,000.00
Sep 30, 2021 253,000.00
Sep 30, 2021 253,000.00
Jun 30, 2021 250,000.00
Jun 30, 2021 250,000.00
Mar 31, 2021 207,000.00
Mar 31, 2021 207,000.00